Showing 1 - 7 results of 7 for search 'Eva De Lago', query time: 0.04s Refine Results
  1. 1
    New Statement about NRF2 in Amyotrophic Lateral Sclerosis and Frontotemporal Dementia

    New Statement about NRF2 in Amyotrophic Lateral Sclerosis and Frontotemporal Dementia by Isabel Lastres-Becker, Eva de Lago, Ana Martínez, Javier Fernández-Ruiz

    Published 2022-08-01
    Get full text
    Article
  2. 2
    Pharmacokinetics of Sativex<sup>®</sup> in Dogs: Towards a Potential Cannabinoid-Based Therapy for Canine Disorders

    Pharmacokinetics of Sativex<sup>®</sup> in Dogs: Towards a Potential Cannabinoid-Based Therapy for Canine Disorders by María Fernández-Trapero, Carmen Pérez-Díaz, Francisco Espejo-Porras, Eva de Lago, Javier Fernández-Ruiz

    Published 2020-02-01
    Get full text
    Article
  3. 3
    Beneficial Effect of Dimethyl Fumarate Drug Repositioning in a Mouse Model of TDP-43-Dependent Frontotemporal Dementia

    Beneficial Effect of Dimethyl Fumarate Drug Repositioning in a Mouse Model of TDP-43-Dependent Frontotemporal Dementia by Ignacio Silva-Llanes, Raquel Martín-Baquero, Alicia Berrojo-Armisen, Carmen Rodríguez-Cueto, Javier Fernández-Ruiz, Eva De Lago, Isabel Lastres-Becker

    Published 2024-09-01
    Get full text
    Article
  4. 4
    Upregulation of CB2 receptors in reactive astrocytes in canine degenerative myelopathy, a disease model of amyotrophic lateral sclerosis

    Upregulation of CB2 receptors in reactive astrocytes in canine degenerative myelopathy, a disease model of amyotrophic lateral sclerosis by María Fernández-Trapero, Francisco Espejo-Porras, Carmen Rodríguez-Cueto, Joan R. Coates, Carmen Pérez-Díaz, Eva de Lago, Javier Fernández-Ruiz

    Published 2017-05-01
    Get full text
    Article
  5. 5
    Preclinical investigation in FAAH inhibition as a neuroprotective therapy for frontotemporal dementia using TDP-43 transgenic male mice

    Preclinical investigation in FAAH inhibition as a neuroprotective therapy for frontotemporal dementia using TDP-43 transgenic male mice by Irene Santos-García, Carmen Rodríguez-Cueto, Patricia Villegas, Fabiana Piscitelli, Anna Lauritano, Che-Kun J. Shen, Vincenzo Di Marzo, Javier Fernández-Ruiz, Eva de Lago

    Published 2023-05-01
    Get full text
    Article
  6. 6
    Decreased endocannabinoid levels in the brain and beneficial effects of agents activating cannabinoid and/or vanilloid receptors in a rat model of multiple sclerosis

    Decreased endocannabinoid levels in the brain and beneficial effects of agents activating cannabinoid and/or vanilloid receptors in a rat model of multiple sclerosis by Ana Cabranes, Katerina Venderova, Eva de Lago, Filomena Fezza, Antonio Sánchez, Leyre Mestre, Marta Valenti, Antonio García-Merino, José Antonio Ramos, Vincenzo Di Marzo, Javier Fernández-Ruiz

    Published 2005-11-01
    Get full text
    Article
  7. 7
    Preclinical Investigation in Neuroprotective Effects of the GPR55 Ligand VCE-006.1 in Experimental Models of Parkinson’s Disease and Amyotrophic Lateral Sclerosis

    Preclinical Investigation in Neuroprotective Effects of the GPR55 Ligand VCE-006.1 in Experimental Models of Parkinson’s Disease and Amyotrophic Lateral Sclerosis by Sonia Burgaz, Concepción García, Claudia Gonzalo-Consuegra, Marta Gómez-Almería, Francisco Ruiz-Pino, Juan Diego Unciti, María Gómez-Cañas, Juan Alcalde, Paula Morales, Nadine Jagerovic, Carmen Rodríguez-Cueto, Eva de Lago, Eduardo Muñoz, Javier Fernández-Ruiz

    Published 2021-12-01
    Get full text
    Article

Search Tools: